ClinicalTrials.Veeva

Menu

Cryotherapy as a Coadjuvant in Crotaline Snakebite Management With Antivenom.

H

Hospital Juarez de Mexico

Status

Completed

Conditions

Snake Bites

Treatments

Procedure: Local cryotherapy.
Biological: F(ab)2 antivenom therapy (antivipmyn®).

Study type

Interventional

Funder types

Other

Identifiers

NCT04470791
HJM 0142/16-R (Other Identifier)

Details and patient eligibility

About

The study aimed to determine the effect of local cryotherapy as a coadjuvant in patients with snakebite treated with F(ab')2 therapy venom at the Hospital Juárez de Mexico.

Full description

Introduction: Local cryotherapy induces vasoconstriction, which leads to a reduction in the inflammatory process. However, the efficacy of local cryotherapy as a coadjuvant in snakebite treatment with F(ab')2 antivenom is unknown.

Objective: Determine the effect of local cryotherapy as a coadjuvant in patients with snakebite treated with F(ab')2 therapy venom.

Material and methods: Subjects with snakebite envenomation accident grade II, according to the Christopher-Rodning classification, were enrolled from the Clinical Toxicology Service of the Hospital Juárez de México. One group of patients received F(ab')2 antivenom therapy (antivipmyn®) plus local cryotherapy, and another group received only F(ab')2 antivenom therapy.

Enrollment

38 patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients of both genders and any age with a snake bite of poison grade II who were admitted to the Clinical Toxicology Service of the Hospital Juárez de México.

Exclusion criteria

  • Patients of both genders and any age with a snake bite of poison grade I, III or IV who were admitted to the Clinical Toxicology Service of the Hospital Juárez de México.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

38 participants in 2 patient groups

F(ab')2 antivenom plus local cryotherapy.
Experimental group
Description:
Group A: patients with a Crotalus snakebite, and grade II envenomation received F(ab')2 antivenom therapy and application of local cryotherapy.
Treatment:
Procedure: Local cryotherapy.
Biological: F(ab)2 antivenom therapy (antivipmyn®).
F(ab')2 antivenom.
Active Comparator group
Description:
Group B: patients who received only F(ab')2 antivenom therapy.
Treatment:
Biological: F(ab)2 antivenom therapy (antivipmyn®).

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems